Enhanced SLC34A2 in breast cancer stem cell-like cells induces chemotherapeutic resistance to doxorubicin via SLC34A2-Bmi1-ABCC5 signaling
Crossref DOI link: https://doi.org/10.1007/s13277-015-4226-0
Published Online: 2015-11-06
Published Print: 2016-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ge, Guanqun
Zhou, Can
Ren, Yu
Tang, Xiaojiang
Wang, Ke
Zhang, Wei
Niu, Ligang
Zhou, Yuhui
Yan, Yu
He, Jianjun
Funding for this research was provided by:
National Natural Science Foundation of China (CN) (81402200)
Text and Data Mining valid from 2015-11-06